You're reading the free version. Trader adds the live tape and alerts.
Start tracking
DNTH Exercise Disclosure
Garcia Marino · SEC Form 4 · Filed Aug 7, 2026
Exercise
Calculated transaction value
$0
Garcia Marino CEO And President
DNTH
Transaction date
Aug 7, 2026
Public filing date
Aug 7, 2026
Filing lag
Filed same day
DNTH daily price context
Close on/before transaction
$108.92
Aug 7, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 40,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001669866-26-000010
Filing cohort
Transactions in this filing
Showing 11 of 11
Trades
11
Issuers
1
Estimated value
$19.35M
Buys / sales
0 / 7
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /de/ DNTH | Sale | Aug 7, 2026 | $258.89K |
| Dianthus Therapeutics, Inc. /de/ DNTH | Exercise | Aug 7, 2026 | $1.06M |
| Dianthus Therapeutics, Inc. /de/ DNTH | Sale | Aug 7, 2026 | $11.24M |
| Dianthus Therapeutics, Inc. /de/ DNTH | Sale | Aug 7, 2026 | $2.38M |
| Dianthus Therapeutics, Inc. /de/ DNTH | Sale | Aug 7, 2026 | $2.58M |
| Dianthus Therapeutics, Inc. /de/ DNTH | Sale | Aug 7, 2026 | $279.01K |
| Dianthus Therapeutics, Inc. /de/ DNTH | Sale | Aug 7, 2026 | $1.12M |
| Dianthus Therapeutics, Inc. /de/ DNTH | Sale | Aug 7, 2026 | $88.61K |
| Dianthus Therapeutics, Inc. /de/ DNTH Current | Exercise | Aug 7, 2026 | $0 |
| Dianthus Therapeutics, Inc. /de/ DNTH | Exercise | Aug 7, 2026 | $0 |
| Dianthus Therapeutics, Inc. /de/ DNTH | Exercise | Aug 7, 2026 | $337.6K |